Fenimore Asset Management Inc Mustang Bio, Inc. Transaction History

Fenimore Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	SELL	$2.58 - $3.36 $38,700 - $50,400	-15,000 Closed	0 $0
Q2 2019 Jul 16, 2019	SELL	$2.66 - $6.28 $61,180 - $144,440	-23,000 Closed	0 $0
Q1 2019 Apr 11, 2019	SELL	$2.95 - $5.61 $44,250 - $84,150	-15,000 Reduced 39.47%	23,000 $78,000
Q4 2018 Jan 11, 2019	BUY	$2.3 - $5.78 $87,400 - $219,640	38,000 New	38,000 $112,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $21M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Fenimore Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Fenimore Asset Management Inc with notifications on news.